The forecasted neoplasm mortality in Brazil shows a year-on-year increase of approximately 1.33% from 2024 to 2028. In 2023, the mortality figure stood at 241,460 deaths, indicating a continuous upward trend. The compound annual growth rate (CAGR) from 2024 to 2028 indicates an average annual increase of around 1.3% in neoplasm-related deaths.
Future trends to watch for include:
- Technological and medical advancements in cancer treatment and diagnosis that may impact mortality rates.
- Public health policies targeting cancer prevention and early detection.
- Socioeconomic factors influencing healthcare access and quality in Brazil.
- Demographic changes, such as aging population, which could affect the incidence of neoplasms.
